These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30685537)

  • 41. Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts.
    Sun M; Rethi B; Krishnamurthy A; Joshua V; Circiumaru A; Hensvold AH; Ossipova E; Grönwall C; Liu Y; Engstrom M; Catrina SB; Steen J; Malmstrom V; Klareskog L; Svensson C; Ospelt C; Wähämaa H; Catrina AI
    Ann Rheum Dis; 2019 Dec; 78(12):1621-1631. PubMed ID: 31481351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis.
    Gudowska M; Gindzienska-Sieskiewicz E; Gruszewska E; Cylwik B; Sierakowski S; Szmitkowski M; Chrostek L
    Rev Bras Reumatol Engl Ed; 2017; 57(3):185-189. PubMed ID: 28535888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance.
    Demoruelle MK; Deane K
    Curr Rheumatol Rep; 2011 Oct; 13(5):421-30. PubMed ID: 21713412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.
    Regueiro C; Nuño L; Ortiz AM; Peiteado D; Villalba A; Pascual-Salcedo D; Martínez-Feito A; González-Alvaro I; Balsa A; González A
    Sci Rep; 2017 Sep; 7(1):12023. PubMed ID: 28931886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts.
    Boeters DM; Gaujoux-Viala C; Constantin A; van der Helm-van Mil AHM
    Semin Arthritis Rheum; 2017 Oct; 47(2):170-174. PubMed ID: 28601249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Ramberg J; Knekt P; Rissanen H; Palosuo T; Risteli J
    Ann Rheum Dis; 2007 Nov; 66(11):1450-5. PubMed ID: 17472989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis.
    Kissel T; van Schie KA; Hafkenscheid L; Lundquist A; Kokkonen H; Wuhrer M; Huizinga TW; Scherer HU; Toes R; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2019 Dec; 78(12):1616-1620. PubMed ID: 31471298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
    Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
    PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production.
    Yamada H; Tsuru T; Otsuka T; Maekawa M; Harada H; Fukuda T; Tsukamoto H; Maeyama A; Yoshizawa S; Wada K; Nakashima Y; Shono E; Yoshizawa S; Jojima H; Kondo M
    Immunol Med; 2020 Jun; 43(2):87-91. PubMed ID: 31994996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-let-7a regulates anti-citrullinated protein antibody-induced macrophage activation and correlates with the development of experimental rheumatoid arthritis.
    Zhu W; Yu J; Qiu S; Liu H; Wang Y; Xu X; Shao L; Zhu L; Jiao Y; Liu F; Zhu X
    Int Immunopharmacol; 2017 Oct; 51():40-46. PubMed ID: 28802150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis.
    England BR; Thiele GM; Mikuls TR
    Curr Opin Rheumatol; 2017 Jan; 29(1):57-64. PubMed ID: 27755123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.
    Alivernini S; Galeazzi M; Peleg H; Tolusso B; Gremese E; Ferraccioli G; Naparstek Y
    Autoimmun Rev; 2017 Nov; 16(11):1096-1102. PubMed ID: 28899798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-citrullinated protein antibodies promote apoptosis of mature human Saos-2 osteoblasts via cell-surface binding to citrullinated heat shock protein 60.
    Lu MC; Yu CL; Yu HC; Huang HB; Koo M; Lai NS
    Immunobiology; 2016 Jan; 221(1):76-83. PubMed ID: 26275591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritis.
    Dekkers J; Toes RE; Huizinga TW; van der Woude D
    Curr Opin Rheumatol; 2016 May; 28(3):275-81. PubMed ID: 26945334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
    Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
    Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
    Wegner N; Lundberg K; Kinloch A; Fisher B; Malmström V; Feldmann M; Venables PJ
    Immunol Rev; 2010 Jan; 233(1):34-54. PubMed ID: 20192991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The term "seropositive" to qualify polyarthritis/rheumatoid arthritis should be banned.
    Goëb V
    Joint Bone Spine; 2018 Jan; 85(1):123. PubMed ID: 28042041
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
    Farid SSh; Azizi G; Mirshafiey A
    Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations.
    Wielosz E; Majdan M; Dryglewska M; Zwolak R
    Adv Clin Exp Med; 2018 Sep; 27(9):1253-1257. PubMed ID: 30024658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.